Robb Knie - Mar 16, 2022 Form 4 Insider Report for Hoth Therapeutics, Inc. (HOTH)

Role
CEO and President, Director
Signature
/s/ Jane H. Springer as Attorney-In-Fact for Robb Knie
Stock symbol
HOTH
Transactions as of
Mar 16, 2022
Transactions value $
$0
Form type
4
Date filed
3/18/2022, 04:15 PM
Next filing
Sep 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOTH Options Award $0 +500K $0.00 500K Mar 16, 2022 Common Stock 500K $0.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were issued pursuant to the Issuer's 2018 Equity Incentive Plan and vested in full upon grant.